Innoviva (INVA) Dividends Paid - Common Growth (1y) (2015 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.26% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 50.59% |
| Jun 30, 2022 | -52.65% |
| Mar 31, 2022 | -69.43% |
| Jun 30, 2021 | 65.91% |
| Mar 31, 2021 | 34.63% |
| Dec 31, 2020 | -76.17% |
| Jun 30, 2020 | 404,966.67% |
| Mar 31, 2020 | 197,525.00% |
| Dec 31, 2019 | 243.72% |
| Jun 30, 2019 | -99.65% |
| Mar 31, 2019 | -78.95% |
| Dec 31, 2018 | 991.46% |
| Sep 30, 2018 | 1,958.88% |
| Jun 30, 2018 | 2,052.50% |
| Mar 31, 2018 | -43.28% |
| Dec 31, 2017 | 332.31% |
| Sep 30, 2017 | -305.77% |
| Jun 30, 2017 | -67.74% |
| Mar 31, 2017 | -90.68% |
| Dec 31, 2016 | -65.24% |
| Sep 30, 2016 | -99.82% |
| Jun 30, 2016 | -99.58% |
| Mar 31, 2016 | -97.50% |
| Dec 31, 2015 | -99.35% |
| Sep 30, 2015 | 2.69% |